ENT Surgical Devices Market By Type (Powered Surgical Instruments, Radiofrequency Hand Pieces, Handheld Instruments) By Application (Hospital, Clinic) and Region - Global Forecast 2026
24th October 2018
- find_in_page Our Research Methodology is based on the following main points:
- Data Collections and Interpretation
- Data Validation
- Final Projections and Conclusion
The global ENT surgical devices market is estimated to value at over US$ 2 Bn in 2018, and is expected to register a CAGR of 5.5%. The report offers in-depth insights, revenue details, and other vital information regarding the global ENT surgical devices market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global ENT surgical devices market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global ENT surgical devices market is segmented on the basis of product type, application, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
ENT surgery is one of the most elaborated fields of surgical specialty services, using advanced technology and a broad range of procedures that include major reconstructive surgeries to correct deformity or injury.
Global ENT Surgical Devices Market Dynamics:
Increasing prevalence of ENT-related diseases and disorders is a key factor expected to drive growth of the global ENT surgical devices market over the forecast period. ENT specialists treat various ear conditions such as otosclerosis, age-related hearing loss, ear infections, etc. Rapidly increasing aging population, coupled with increasing prevalence of hearing-related problems such as tinnitus among all age groups are among major factors expected to propel demand for ENT surgical devices in the near future.
In addition, increasing technological advancements and introduction of innovative and advanced ENT surgical systems are other factors expected to further fuel growth of the global ENT surgical devices market over the forecast period. For instance, In April 2018, Acclarent Inc. which is a part of the Johnson & Johnson Medical Devices Companies, launched TruDi – a real-time, three-dimensional (3D) navigation system in the US – for ENT procedures performed in the operating room and surgeon’s office. In addition, in September 2017, Medtronic Plc. launched StealthStation ENT surgical navigation system for otolaryngology procedures.
Furthermore, minimally invasive ENT surgical procedures offer various benefits over traditional surgeries, thereby facilitating faster recovery time and shorter hospital stay, and also reduce healthcare expenditure and time of recovery of patients, which is another factor expected to drive growth of the target market to a significant extent over the forecast period.
However, lack of proper reimbursement policies for ENT surgical procedures, particularly in developing and under developed economies is a major factor that could hamper growth of the global ENT surgical devices market over the forecast period.
Market analysis by type:
On the basis of type segmentation, the handheld instruments segment is expected to contribute major revenue share and is estimated to maintain its dominance over the forecast period. The handheld instruments segment is estimated to register highest CAGR of over 5.7%, owing to increasing demand for handheld instruments for ENT surgical treatment.
Market analysis by application:
On the basis of application segmentation, the hospital segment is expected to contribute major revenue share of the market and is expected to maintain its dominance over the forecast period. The hospital segment is projected to register highest CAGR over 5.5% over the forecast period, owing to availability of various reimbursement policies in hospitals and increasing number of patent pool.
Analysis by Region:
The market in North America accounted for significant revenue share of over 25% in the global ENT surgical devices market in 2017. Improved healthcare infrastructure and presence of advanced medical facilities across various countries in this region, especially the US, are major factors driving growth of the North America ENT surgical devices market.
In addition, increasing government initiatives for spreading awareness about various ENT disorders such as ear infections, sinus infections, and sleep apnea, coupled with favorable reimbursement policies in countries in the region, are among other factors expected to boost demand for ENT surgical devices market, and in turn are expected to drive growth of the North America ENT surgical devices market over the forecast period.
The market in Asia Pacific is expected to account for second-highest revenue share in the global ENT surgical devices market, owing to increasing incidence of various ENT diseases, presence of large patient pool, and increasing government initiatives for spreading awareness about treatment of various diseases, especially in emerging economies.
In addition, increasing consumption of tobacco, India contributes to around 60% of head and neck cancer — inside the mouth, the nose, and the throat, and this factor is expected to increase numbers of ear and nose surgeries in the country, which is in turn is expected to create demand for ENT surgical devices and will support growth of the Asia Pacific ENT surgical devices market.
The market in Middle East & Africa is expected to contribute moderately to the global ENT surgical devices market. Humid climate and high presence of sand particles results in ear infections and sinusitis problems in several countries in the Middle East. Rising prevalence of ear infections and increasing demand for comprehensive ENT services are major factors driving growth of the ENT surgical devices market in the UAE.
The market in South America is expected to account for revenue share of around 13% owing to growing geriatric population, increasing ear-related disorders, and increasing number of ear surgeries in countries such as Brazil and Columbia which is expected to create demand for the ENT surgical devices. In 2015, According to the International Society of Aesthetic Plastic Surgery, 42,240 ear surgeries were performed in Brazil, and 7,192 ear surgeries performed in Columbia. In addition, technological development, innovative product launches, and merger and acquisition activities are expected to create potential revenue opportunities for players operating in the target market over the forecast period. For instance, in October 2018, Medtronic plc launched Control WorkflowSM, to be used with the SynchroMed II intrathecal drug delivery system (Medtronic pain pump), that will help physicians wean patients off oral opioids and treat chronic intractable pain
Global ENT surgical devices market segmentation:
Segmentation on the basis of type:
- Powered Surgical Instruments
- Radiofrequency Hand Pieces
- Handheld Instruments
- Others (Balloon Sinus Dilation Devices, ENT Supplies, Ear Tubes, and Voice Prosthesis Devices)
Segmentation on the basis of application:
Segmentation on the basis of region:
- North America
- Asia Pacific
- South America
- Middle East & Africa
- Medtronic plc
- Johnson & Johnson (Acclarent, Inc.)
- Stryker Corporation
- Smith & Nephew plc
- Olympus Corporation
- Braun Melsungen AG
- KARL STORZ GmbH & Co. KG
- Spiggle & Theis Medizintechnik GmbH
- CONMED Corporation
- Happersberger otopront GmbH
- Zhejiang Tiansong Medical Instrument Co. Ltd.
- Reda Instrumente GmbH
- Cochlear Limited and HOYA Corporation (PENTAX Medical)
- 1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Type
- 2.2.2 Market Snapshot, By Application
- 2.2.3 Market Snapshot, By Region
- 2.2.4 Prudour Opportunity Map Analysis
Request for Customization
Don't just take our word. We are trusted by these great companies!